Deloron P, Steketee R W, Campbell G H, Peyron F, Kaseje D C, Brandling-Bennett A D
Malaria Branch, Centers for Disease Control, Atlanta, Georgia 30333.
Trans R Soc Trop Med Hyg. 1989 Jan-Feb;83(1):58-62. doi: 10.1016/0035-9203(89)90705-0.
To investigate potential mechanisms for pregnancy-associated alterations in the immune response to malaria, we tested plasma samples from Plasmodium falciparum-infected nulligravida (42), primigravida (23) and multigravida (38) Kenyan women for reactivity to the ring-infected erythrocyte surface antigen (RESA) by a modified indirect fluorescent antibody assay and to synthetic peptides derived from amino acid sequences of RESA and the circumsporozoite (CS) protein of P. falciparum by an enzyme-linked immunosorbent assay. Reactivity to RESA showed the lowest titres in primigravid women, intermediate titres in nulligravid women and the highest titres in multigravid women (loge mean antibody = 3.28, 4.64, and 5.28, respectively, P less than 0.03), but was not associated with initial parasite density or response to chloroquine treatment. No relationship in antibody reactivity to the 3 synthetic peptides of the RESA molecule was observed by gravidity (0, 1, or greater than or equal to 2), age, initial parasite density or response to treatment. Levels of antibody to the synthetic peptides of the CS protein increased with age and were higher in gravid than in nulligravid women in the 15-19 year age group. The increased malaria prevalence and parasite density and the decreased response to antimalarial treatment in pregnant women is not explained by lower levels of antibody to RESA or CS protein during pregnancy.
为了研究妊娠相关的疟疾免疫反应改变的潜在机制,我们通过改良的间接荧光抗体试验检测了来自肯尼亚感染恶性疟原虫的未孕女性(42例)、初孕女性(23例)和经产妇(38例)的血浆样本对环状感染红细胞表面抗原(RESA)的反应性,并通过酶联免疫吸附试验检测了对源自RESA氨基酸序列和恶性疟原虫子孢子(CS)蛋白的合成肽的反应性。对RESA的反应性在初孕女性中滴度最低,未孕女性中滴度中等,经产妇中滴度最高(自然对数平均抗体分别为3.28、4.64和5.28,P小于0.03),但与初始寄生虫密度或对氯喹治疗的反应无关。按妊娠次数(0次、1次或大于或等于2次)、年龄、初始寄生虫密度或治疗反应观察,未发现对RESA分子的3种合成肽的抗体反应性有相关性。CS蛋白合成肽的抗体水平随年龄增加而升高,在15 - 19岁年龄组中,妊娠女性的抗体水平高于未孕女性。妊娠期间对RESA或CS蛋白的抗体水平较低并不能解释孕妇中疟疾流行率和寄生虫密度增加以及对抗疟治疗反应降低的现象。